MENU
NBIX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Neurocrine Biosciences (NBIX) Earnings Date & Reports

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

NBIX is expected to report earnings to fall 17.58% to $1.36 per share on November 04

Neurocrine Biosciences NBIX Stock Earnings Reports
Q3'25
Est.
$1.36
Q2'25
Beat
by $0.69
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.12
Q3'24
Beat
by $0.29
The last earnings report on July 30 showed earnings per share of $1.65, beating the estimate of 95 cents. With 1.23M shares outstanding, the current market capitalization sits at 13.72B.
View a ticker or compare two or three
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NBIX showed earnings on July 30, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a product based biopharmaceutical company

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
12780 El Camino Real
Phone
+1 858 617-7600
Employees
1400
Web
https://www.neurocrine.com